Call Us
Gemcitabine for Injection

Gemcitabine for Injection

1 USD ($)/Box

Product Details:

  • Salt Composition Gemcitabine Hydrochloride
  • Indication Used in treatment of various cancers such as pancreatic, ovarian, breast and non-small cell lung cancer
  • Dosage Form Lyophilized Powder for Injection
  • Enzyme Types Other
  • Feature Other
  • Ingredients Other
  • Application Other
  • Click to View more
X

Gemcitabine for Injection Price And Quantity

  • 1 USD ($)/Box
  • 100 Box

Gemcitabine for Injection Product Specifications

  • Between 7.0 and 9.0 in reconstituted solution
  • Other
  • Normal Smell
  • Used in treatment of various cancers such as pancreatic, ovarian, breast and non-small cell lung cancer
  • Other
  • White to off-white lyophilized powder
  • Store at cool and dry place.
  • 2 Years
  • Other
  • Other
  • Lyophilized Powder for Injection
  • Gemcitabine Hydrochloride
  • As depicted on vial label (varies by manufacturer)
  • Intravenous infusion
  • 200 mg and 1 g per vial
  • Meets USP/BP specifications
  • Single vial packed in a carton with package insert
  • Adults under medical supervision
  • Handle with specialized cytotoxic precautions
  • Soluble in water for injection
  • Reconstitute with 0.9% Sodium Chloride Injection, USP
  • Prescription only medication

Gemcitabine for Injection Trade Information

  • surat
  • Paypal, Cash Against Delivery (CAD), Cash on Delivery (COD), Letter of Credit (L/C), Western Union, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Delivery Point (DP), Days after Acceptance (DA), Cash in Advance (CID), Cheque, Cash Advance (CA)
  • 1000000 Box Per Month
  • 4 Days
  • Contact us for information regarding our sample policy
  • 1 Vial
  • Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa
  • Manipur, Dadra and Nagar Haveli, Himachal Pradesh, Meghalaya, Andaman and Nicobar Islands, Uttarakhand, Lakshadweep, South India, North India, East India, West India, Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Chandigarh, Delhi, Goa, Haryana, Jammu and Kashmir, Kerala, Madhya Pradesh, Maharashtra, Mizoram, Nagaland, Punjab, Pondicherry, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Daman and Diu, Gujarat, Rajasthan, Karnataka, Central India, Odisha, Jharkhand, Chhattisgarh, Uttar Pradesh, All India
  • ISO/GMP/c-GMP/WHOGMP/USFDA/EUGMP.

Product Description

Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofGemcitabine for Injectionfrom Surat, Gujarat, India. Gemcitabine For Injection used as a first-line treatment alone for pancreatic cancer, and in combination with cisplatin for advanced or metastatic bladder cancer and advanced or metastatic non-small cell lung cancer.

Tags: Gemcitabine for Injection manufacturer, Gemcitabine forInjection exporter, Gemcitabine for Injection supplier, and Gemcitabine forInjection, whogmp approved Gemcitabine for Injection manufacturer and supplier,Gemcitabine for Injection distributor, Gemcitabine for Injection shipper, Gemcitabine ForInjection200 mgGemcitabine for Injection 200 mgsupplier,Gemcitabine for Injection 200 mg.

ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturingfacility in Gujarat, India.

Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.

Export Country:Saintroy LifescienceGemcitabine forInjection export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.



Targeted Cancer Therapy for Adults

Gemcitabine for Injection offers a reliable treatment option for adults with specific cancers, namely pancreatic, ovarian, breast, and non-small cell lung cancer. It is administered under the direction of a healthcare professional, ensuring tailored care for eligible patients. With established clinical benefits and compliance with international standards, patients and providers can trust its efficacy and quality.


Safe Preparation and Handling Procedures

As a cytotoxic medication, Gemcitabine requires specialized handling measures to safeguard both healthcare providers and the environment. The medication is reconstituted with 0.9% Sodium Chloride Injection, USP, ensuring optimal solubility for intravenous infusion. Comprehensive packaging, including a clear package insert, supports precise and safe administration.


Flexible Dosage Strengths to Meet Clinical Needs

Available in 200 mg and 1 g strengths per vial, Gemcitabine for Injection allows for customized dosing as required by individual treatment regimens. This flexibility supports oncologists and pharmacists in delivering treatments that are aligned with specific patient needs, maximizing therapeutic benefit while maintaining safety standards.

FAQ's of Gemcitabine for Injection:


Q: How should Gemcitabine for Injection be reconstituted for administration?

A: Gemcitabine for Injection must be reconstituted using 0.9% Sodium Chloride Injection, USP. Carefully follow the package insert instructions for accurate dilution to ensure safety and efficacy. Only trained healthcare professionals should perform this procedure under cytotoxic precautions.

Q: What types of cancers can Gemcitabine for Injection treat?

A: Gemcitabine for Injection is indicated for the treatment of pancreatic, ovarian, breast, and non-small cell lung cancer in adult patients. Its efficacy is supported for these specific cancer types under a healthcare provider's supervision.

Q: When should Gemcitabine for Injection be administered to patients?

A: This medication is administered according to the specific cancer treatment protocol prescribed by an oncologist. Patients typically receive Gemcitabine as part of scheduled intravenous infusions, tailored to their individual treatment plans.

Q: Where should Gemcitabine for Injection be stored before use?

A: The vials should be stored in a cool and dry place at the facility, ensuring protection from excessive heat and humidity. Always keep the medication in its original carton until it is ready for use, and check the package insert for any additional storage guidelines.

Q: What precautions should be taken during the handling and preparation of Gemcitabine for Injection?

A: Due to its cytotoxic nature, always handle Gemcitabine for Injection with specialized protective equipment, including gloves and a mask if necessary. Follow institutional protocols for cytotoxic drug handling and disposal to protect both staff and the environment.

Q: What are the benefits of using Gemcitabine for Injection for cancer treatment?

A: Gemcitabine for Injection offers targeted, effective therapy for various cancers, and its flexibility in dosing allows for individualized treatment plans. The medication is manufactured in compliance with USP/BP standards, ensuring quality and patient safety.

Q: Who can prescribe and administer Gemcitabine for Injection?

A: Only licensed medical professionals-typically oncologists or healthcare providers specializing in cancer treatment-can prescribe and oversee the administration of Gemcitabine for Injection. This ensures that the medication is used appropriately and safely for eligible adult patients.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anticancer Injection' category



Back to top
trade india member
SAINTROY LIFESCIENCE All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.